drug
medroxyprogesterone
Marketedupdated 3mo agoby Xiromed LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- drugDEPO-SUBQ PROVERA 104170 co-mentions · 57 sources
- drugDEPO-PROVERA170 co-mentions · 57 sources
- tagApproval110 co-mentions · 55 sources
- drugmedroxyprogesterone acetate60 co-mentions · 57 sources
- companyEugia US LLC7 co-mentions · 2 sources
- tagRecall3 co-mentions · 2 sources
- companyEugia Pharma Specialties Ltd2 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying medroxyprogesterone
- phase3Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
- phase2A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- phase4Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa
- phase3Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
- phase4Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.
- phase2Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
- phase1Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that